Early Introduction and Rise of the Omicron Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variant in Highly Vaccinated University Populations

Author:

Petros Brittany A1234ORCID,Turcinovic Jacquelyn56,Welch Nicole L27,White Laura F8,Kolaczyk Eric D910,Bauer Matthew R211,Cleary Michael12,Dobbins Sabrina T2,Doucette-Stamm Lynn13,Gore Mitch14,Nair Parvathy15,Nguyen Tien G2,Rose Scott14,Taylor Bradford P16,Tsang Daniel14,Wendlandt Erik14,Hope Michele12,Platt Judy T17,Jacobson Karen R18,Bouton Tara18,Yune Seyho19,Auclair Jared R202122,Landaverde Lena1323,Klapperich Catherine M131724,Hamer Davidson H518242526,Hanage William P16,MacInnis Bronwyn L2,Sabeti Pardis C21527282930,Connor John H5631,Springer Michael12

Affiliation:

1. Department of Systems Biology, Harvard Medical School , Boston, Massachusetts , USA

2. Broad Institute of Massachusetts Institute of Technology and Harvard , Cambridge, Massachusetts , USA

3. Division of Health Sciences and Technology, Harvard Medical School and Massachusetts Institute of Technology , Cambridge, Massachusetts , USA

4. Harvard/Massachusetts Institute of Technology, MD-PhD Program , Boston, Massachusetts , USA

5. National Emerging Infectious Diseases Laboratories , Boston, Massachusetts , USA

6. Bioinformatics Program, Boston University , Boston, Massachusetts , USA

7. Harvard Program in Virology, Division of Medical Sciences, Harvard Medical School , Boston, Massachusetts , USA

8. Department of Biostatistics, School of Public Health, Boston University , Boston, Massachusetts , USA

9. Department of Mathematics & Statistics, Boston University , Boston, Massachusetts , USA

10. Rafik B. Hariri Institute for Computing and Computational Science and Engineering, Boston University , Boston, Massachusetts , USA

11. Harvard Program in Biological and Biomedical Sciences, Division of Medical Sciences, Harvard Medical School , Boston, Massachusetts , USA

12. Harvard University Clinical Laboratory, Harvard University , Cambridge, Massachusetts , USA

13. Boston University Clinical Testing Laboratory, Boston University Boston, Massachusetts , USA

14. Integrated DNA Technologies, Inc , Coralville, Iowa , USA

15. Howard Hughes Medical Institute , Chevy Chase, Maryland , USA

16. Center for Communicable Disease Dynamics, Department of Epidemiology, Harvard T.H. Chan School of Public Health , Boston, Massachusetts , USA

17. Boston University Student Health Services , Boston, Massachusetts , USA

18. Section of Infectious Diseases, Boston University School of Medicine and Boston Medical Center , Boston, Massachusetts , USA

19. Student Affairs, Northeastern University , Boston, Massachusetts , USA

20. Department of Chemistry and Chemical Biology, Northeastern University , Boston, Massachusetts , USA

21. Life Sciences Testing Center, Northeastern University , Burlington, Massachusetts , USA

22. Biopharmaceutical Analysis and Training Laboratory , Burlington, Massachusetts , USA

23. Department of Biomedical Engineering, Boston University , Boston, Massachusetts , USA

24. Boston University Precision Diagnostics Center, Boston University , Boston, Massachusetts , USA

25. Department of Global Health, Boston University School of Public Health , Boston, Massachusetts , USA

26. Center for Emerging Infectious Disease Research and Policy, Boston University , Boston, Massachusetts , USA

27. Department of Organismic and Evolutionary Biology, Harvard University , Cambridge, Massachusetts , USA

28. Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Harvard University , Boston, Massachusetts , USA

29. Department of Medicine, Division of Infectious Diseases, Massachusetts General Hospital , Boston, Massachusetts , USA

30. Massachusetts Consortium on Pathogen Readiness , Boston, Massachusetts , USA

31. Department of Microbiology, Boston University School of Medicine , Boston, Massachusetts , USA

Abstract

Abstract Background The Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is highly transmissible in vaccinated and unvaccinated populations. The dynamics that govern its establishment and propensity toward fixation (reaching 100% frequency in the SARS-CoV-2 population) in communities remain unknown. Here, we describe the dynamics of Omicron at 3 institutions of higher education (IHEs) in the greater Boston area. Methods We use diagnostic and variant-specifying molecular assays and epidemiological analytical approaches to describe the rapid dominance of Omicron following its introduction into 3 IHEs with asymptomatic surveillance programs. Results We show that the establishment of Omicron at IHEs precedes that of the state and region and that the time to fixation is shorter at IHEs (9.5–12.5 days) than in the state (14.8 days) or region. We show that the trajectory of Omicron fixation among university employees resembles that of students, with a 2- to 3-day delay. Finally, we compare cycle threshold values in Omicron vs Delta variant cases on college campuses and identify lower viral loads among college affiliates who harbor Omicron infections. Conclusions We document the rapid takeover of the Omicron variant at IHEs, reaching near-fixation within the span of 9.5–12.5 days despite lower viral loads, on average, than the previously dominant Delta variant. These findings highlight the transmissibility of Omicron, its propensity to rapidly dominate small populations, and the ability of robust asymptomatic surveillance programs to offer early insights into the dynamics of pathogen arrival and spread.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Reference43 articles.

1. Outbreak caused by the SARS-CoV-2 Omicron variant in Norway, November to December 2021;Brandal;Euro Surveill,2021

2. Increased risk of SARS-CoV-2 reinfection associated with emergence of the Omicron variant in South Africa;Pulliam;bioRxiv,2021

3. Effectiveness of BNT162b2 vaccine against Omicron variant in South Africa;Collie;N Engl J Med,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3